证券代码：600137 证券简称：浪莎股份 公告编号：2025-018 四川浪莎控股股份有限公司 关于召开2024年年度股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东会类型和届次 2024年年度股东会 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (四)现场会议召开的日期、时间和地点 召开的日期时间：2025 年 6 月 20 日10 点 00 分 召开地点：浙江省义乌市四海大道浪莎三期浪莎内衣有限公司会议厅 (五)网络投票的系统、起止日期和投票时间。 股东会召开日期：2025年6月20日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 网络投票系统：上海证券交易所股东会网络投票系统 网络投票起止时间：自2025 年 6 月 20 日 至2025 年 6 月 20 日 （2）议案 8 至议案 13 于 2025 年 5 月 27 日在上海证券报和上海证券交易所网 站披露。 二、 会议审 ...

证券代码：600137 股票简称：浪莎股份 编号：临 2025-016 四川浪莎控股股份有限公司 第十一届监事会第九次会议决议公告 本项议案尚需提交公司股东会审议通过。 特此公告。 四川浪莎控股股份有限公司 监 事 会 2025 年 5 月 25 日 1 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 四川浪莎控股股份有限公司于 2025 年 5 月 25 日在浪莎三期浪莎 内衣有限公司会议室召开了第十一届监事会第九次会议，会议由监事 会主席陈筱斐主持。会议应到监事 3 名，实到监事 3 名。公司董事会 秘书列席会议，会议符合《公司法》、《公司章程》规定。经出席会议 监事审议，现将会议审议通过事项公告如下： 3 票同意，0 票反对，0 票弃权，审议通过了《关于取消监事会 并修订（公司章程）议案》。 根据《中华人民共和国公司法》《上市公司章程指引》等规定， 由董事会审计委员会行使监事会的相关职权，公司拟取消监事会及监 事设置，《监事会议事规则》不再施行，并对《公司章程》进行修订。 关于取消监事会并修订【公司章程】的具体内 ...

证券代码：600137 股票简称：浪莎股份 编号：临 2025-015 四川浪莎控股股份有限公司 第十一届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 四川浪莎控股股份有限公司于 2025 年 5 月 25 日在浪莎三期浪莎 内衣有限公司会议室召开了第十一届董事会第十三次会议，会议于 2025 年 5 月 15 日以微信和电子邮件形式书面通知公司董事、监事、 总经理、副总经理等公司高级管理人员。会议由公司第十一届董事会 董事长翁荣弟主持。会议应到董事 7 名、实到董事 6 名，董事翁晓锋 因公出差，未出席会议。公司监事会 2 名监事及董事会秘书列席会议。 会议符合《公司法》、《公司章程》规定，会议合法有效。经出席会议 的 6 名董事审议，以书面记名方式进行了投票，现将会议审议通过事 项公告以下： 一、6 票同意，0 票反对，0 票弃权，审议通过了《关于取消监 事会并修订【公司章程】的议案》。 根据《中华人民共和国公司法（2023 年修订）》（以下简称《公 司法》）《上市公司章程指引（202 ...

Market Overview - On May 23, the A-share market showed strong performance before noon but retreated in the afternoon, with the Shanghai Composite Index down 0.94% to 3348.37 points, the Shenzhen Component Index down 0.85% to 10132.41 points, and the ChiNext Index down 1.18% to 2021.50 points [2] - The total market turnover was 118.26 billion yuan, an increase of 42.9 billion yuan compared to the previous trading day [2] - Leading sectors included pharmaceuticals, automotive supply chains, and controllable nuclear fusion, while previously popular micro-cap stocks continued to adjust [2] Pharmaceutical Sector - The pharmaceutical sector experienced a strong surge, with leading innovative drug company Heng Rui Pharmaceutical listing on the Hong Kong Stock Exchange and seeing its stock price rise over 25%, boosting the entire innovative drug industry chain [3] - A-share pharmaceutical stocks rose against the trend, with companies like Hai Chen Pharmaceutical and Zhong Sheng Pharmaceutical hitting the daily limit, while Hua Sen Pharmaceutical and Cheng Da Pharmaceutical also saw gains [3] - Multiple innovative drug companies announced they would showcase their research results at the 2025 American Society of Clinical Oncology (ASCO) annual meeting from May 30 to June 3 [3] - The market's expectations for domestic innovative drugs going global were heightened following the news of a dual-antibody new drug licensing collaboration between Sanofi and Pfizer [3] - According to NextPharma, Chinese pharmaceutical companies completed 41 overseas licensing transactions in Q1 2025, totaling 36.9 billion USD, nearing the total for the entire year of 2023 [3] - From 2015 to 2024, China ranked first globally in the cumulative number of original innovative drugs developed [4] - Zhonghang Securities noted that the innovative drug industry is undergoing profound changes, with companies enhancing their core advantages and transitioning from followers to significant players in international competition [3] Micro-Cap Stocks - Micro-cap stocks initially performed well but began to adjust from mid-week, with high-profile stocks like Nanjing Port and Langsha experiencing significant fluctuations [5] - Wangzi New Materials gained attention from active market funds, achieving a limit-up on May 23 and recording five consecutive trading days of gains, effectively doubling in value [5] - According to Founder Securities, the dominance of micro-cap stocks has been a notable feature of the A-share market this year, with strong mean reversion properties observed in small-cap styles [5] - The outlook for the market suggests that the trend favoring micro-cap stocks may continue, supported by factors such as a stable capital market, ongoing economic transformation, and sustained liquidity [5]

Market Performance - On May 23, major market indices experienced fluctuations and closed lower, with A-shares trading volume reaching 1.18 trillion yuan, and over 1,100 stocks closing higher, including 52 stocks hitting the daily limit [1] - For the week, the Shanghai Composite Index fell by 0.57%, the ChiNext Index dropped by 0.88%, and the STAR Market 50 Index decreased by 1.47% [1] Individual Stock Performance - Over 1,600 stocks rose this week, with 22 stocks gaining over 30%. Notably, six stocks surged over 50%, with the largest increase being 99.96% for Sanofi [1][2] - Other significant gainers included Huibo Yuntong (301316) and Binhai Energy (000695), both of which saw weekly increases exceeding 60% [1][2] Sector Analysis - Among the stocks that rose over 30%, the pharmaceutical and biological sector had six representatives, followed by light industry manufacturing with three stocks [1] Historical Highs - On May 23, 17 stocks reached historical closing highs, with the pharmaceutical and biological, mechanical equipment, and automotive sectors showing a concentration of high performers [3][4] - The average increase for stocks reaching historical highs was 8.20%, with notable gainers including Xintiandi (301277) and Zhongzhou Special Materials (300963) [3] Institutional Activity - On May 23, ten stocks saw net purchases from institutions, with Yixin Tang (002727) leading at a net buy of 102 million yuan [5][6] - Conversely, institutions sold off stocks such as Hongchuang Holdings (002379) and Tianqimo (002510), each experiencing net sales exceeding 50 million yuan [5][6] Northbound Capital Flow - Northbound capital was present in nine stocks on the trading board, with net purchases in three stocks: Xue Ren Shares (002639), Huibo Yuntong, and Jinlongyu (002882) [7] - Yixin Tang faced the highest net sell-off from northbound capital, totaling 68.98 million yuan [7] Company Announcements - Zhongjin Gold (600489) plans to inject four companies, including Inner Mongolia Jintao, into the company to resolve competition issues [8] - Huakang Clean (301235) won a bid for a healthcare project with a contract value of 60.24 million yuan and a duration of 120 days [8] - Weier Shares (603501) intends to issue H-shares and list on the Hong Kong Stock Exchange [9] - Yunchongma (603130) plans to raise no more than 640 million yuan for a project to produce DTY silk and high-performance leather base fabric [9]

Group 1 - A-shares experienced a pullback on Friday, with all three major indices turning negative, and the ChiNext index dropping over 1% [1] - The Hang Seng Tech Index also reversed its earlier gains, which had exceeded 1% [1] - A50 futures index saw a sharp decline, reporting a drop of 0.75% [3] Group 2 - Government bond futures turned upward across the board, with the 30-year main contract rising by 0.06%, the 10-year main contract up by 0.06%, the 5-year main contract increasing by 0.07%, and the 2-year main contract gaining 0.04% [5] - Gold prices surged, with New York gold futures rising by over 1%, while A-share gold stocks rallied, with Western Gold hitting the limit up, and other stocks like Xiaocheng Technology, Mankalon, Chifeng Gold, and Hunan Gold also seeing gains [5] Group 3 - U.S. President Trump urged the EU to reduce tariffs, warning of more tariffs if they do not comply [7] - Japanese Prime Minister discussed U.S. tariff measures with Trump, maintaining a stance on the removal of tariffs, and also addressed diplomatic and security issues [7] Group 4 - A significant policy briefing is scheduled for next Tuesday, where officials will discuss reforms and innovations in national-level economic and technological development zones [8]

高位人气股 浪莎股份午后触及跌停，上演"天地板"，成交超5亿元。该股此前走出4连板，今早以涨停 开盘。 ...

证券代码：600137 股票简称：浪莎股份 编号：临 2025-014 一、股票交易异常波动的具体情况 四川浪莎控股股份有限公司（以下简称： "公司"、"本公司"） 股票交易于 2025 年 5 月 21 日、22 日连续两个交易日内日收盘价 格涨幅偏离值累计超过 20%，触及《上海证券交易所交易规则》规 定的异常波动标准，属于股票交易异常波动。 二、公司关注并核实的相关情况 四川浪莎控股股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带责任。 重要内容提示： 公司股票交易连续两个交易日内日收盘价格涨幅偏离值累计 超过 20%， 属于股票交易异常波动。 经公司自查并向控股股东及实际控制人发函查证回复，不存 在应披露而未披露的重大信息。 公司董事会确认：本公司没有任何根据《股票上市规则》等有关 规定应披露而未披露的事项或与该等事项有关的筹划和意向，董事会 也未获悉根据《股票上市规则》等有关规定应披露而未披露的、对本 公司股票交易价格可能产生较大影响的信息。 四、相关风险提示 （一）市场交易风险。 ...

Core Viewpoint - The company, Sichuan Langsha Holdings Co., Ltd., has experienced significant stock price fluctuations, with consecutive trading days of price increases, raising concerns about potential market speculation and risks associated with high share pledges by major shareholders [2][3]. Group 1: Stock Performance and Market Risks - The company's stock hit the daily limit on May 19 and 20, 2025, and continued to rise on May 21, indicating abnormal trading activity [2][3]. - The static price-to-earnings (P/E) ratio is 93.28, while the dynamic P/E ratio is 58.54, suggesting that the company's valuation is significantly higher than the industry average [2][3]. - Investors are advised to be cautious due to the potential for stock price speculation, as the company's fundamentals have not changed [2][3]. Group 2: Shareholder Pledge Risks - The controlling shareholder, Langsha Holdings Group Co., Ltd., holds 42.664755 million shares, with 27 million shares pledged, resulting in a pledge ratio of 63.28%, which exceeds 50% [2][3]. - The high pledge ratio of the controlling shareholder poses additional risks for investors [3]. Group 3: Significant Shareholder Activities - On May 21, 2025, the company received a notice from a major shareholder, Tibet Giant Wave Technology Co., Ltd., regarding the sale of 972,200 shares, amounting to approximately 21.86 million yuan [4]. - As of the announcement date, the company and its controlling shareholders have no undisclosed significant matters, including major asset restructuring or share repurchases [4]. Group 4: Share Pledge Release - Tibet Giant Wave Technology Co., Ltd. released 1,037,888 shares from pledge, which is 6.34% of its total holdings, while still having 15.77% of the company's total shares pledged [8]. - The release of shares from pledge does not affect the governance structure or the controlling shareholder's status [10].

Group 1 - Wangzi New Materials (002735.SZ) announced that its subsidiary, Ningbo Xinrong Electric Technology Co., Ltd., provides energy storage capacitors, which account for less than 3% of the company's total revenue for 2024, indicating no significant impact on performance in the short term [1] - Wangzi New Materials' controlling shareholder, Wang Jinjun, sold 1.11 million shares, representing 0.29% of the total share capital, as part of a planned reduction of up to 11.46 million shares, or approximately 3% of total share capital [1] - The stock price of Wangzi New Materials has doubled since its recent low of 7.51 CNY per share on April 9, with a closing price of 15.67 CNY per share today, reflecting a 2.69% increase [1] Group 2 - Langsha Co., Ltd. (600137.SH) issued a risk warning, stating that its fundamentals have not changed and its valuation is significantly higher than the industry average, indicating potential speculative risks [2] - The controlling shareholder of Langsha, Langsha Holdings Group Co., Ltd., has a high pledge ratio, with 63.28% of its shares (27 million out of 42.66 million shares) pledged [2] - Langsha also reported that its shareholder, Tibet Jiulang Technology Co., Ltd., sold 972,200 shares for 2.1855 million CNY, reducing its holding to 15.84% [4]